[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].
Trillet-Lenoir
V
V
Unité fonctionnelle d'oncologie médicale, Centre hospitalier Lyon-Sud, France.
Freyer
G
G
D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000097:blood* / Q000473:pathology; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011003:Ploidies
D014408:Biomarkers, Tumor